drugset / Trial / NCT00165347
Protein Tyrosine Kinases (PTK) in Multiple Myeloma
Phase 2
Completed
10 enrolled
Dana-Farber Cancer Institute
Brigham and Women's Hospital · collabNovartis · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether or not cancer cells in the body are affected by PTK and whether it affects the growth of these cells.
Timeline
- Start
- 2003-12
- Primary completion
- 2006-10
- Completion
- 2006-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | vatalanib | Small molecule | — | Oral |